NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Co-diagnostics, Inc. CODX
10 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$622,489
▼ 84.1% vs FY2024
EPS · FY25
$-35.25
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-125.9%
Net margin · FY25
-7533.6%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 622,489.00
Revenue, FY2025 · full 10-year series below
Revenue
Net income
The company lost 7534 cents on every revenue dollar this year.
Per share
USD -35.25
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-125.9%
Return on equity, FY2025
ROE
Operating margin-8058.8%
Net margin-7533.6%
Return on assets-106.2%
Each USD of equity lost 126 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
−61.6% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−73.7%
−61.6%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.00B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 24.7M
total assets, end of FY2025
Total assetsUSD 24.7M
EquityUSD 20.6M
CashUSD 11.9M
Current ratio3.87×
Equity funds 83% of total assets.
History
10 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue $B
0.0
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
·
Operating income $B
−0.1
−0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
·
−0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
−0.0
0.0
−0.0
−0.0
0.0
0.0
·
·
·
·
Net income $B
−0.0
−0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−35.25
−37.22
−1.20
−0.45
1.23
1.52
−0.37
−0.50
−0.63
·
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
ROE %
−125.9
−54.0
−35.3
−11.4
36.4
124.1
−1826.4
−449.3
−1626.1
·
Shares out B
0.00
0.00
0.03
0.03
0.03
0.03
0.02
0.01
0.01
0.01
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
38 of 38
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed